Related Experiment Video
Updated: Apr 17, 2026
13:01
Mammary Transplantation of Stromal Cells and Carcinoma Cells in C57BL/6J Mice
Published on: August 12, 2011
18.3K
Changes in the serum protein composition in mice with transplanted Ehrlich's carcinoma
N G Kormosh1, R Kh Ziganshin, V O Shender
1N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia, nkormosh@hotmail.com.
Bulletin of Experimental Biology and Medicine
|February 25, 2015
Summary
Serum from tumor-bearing mice contains factors that stimulate cancer growth. Researchers identified new proteins in the serum, suggesting a new avenue for cancer research and treatment development.
Area of Science:
- Oncology
- Proteomics
- Immunology
Background:
- Ehrlich's carcinoma in mice is associated with specific factors in blood serum.
- Tumor growth can be influenced by serum components, indicating the presence of bioactive molecules.
Purpose of the Study:
- To investigate the presence and nature of tumor-specific factors in the serum of mice with Ehrlich's carcinoma.
- To identify novel proteins in the serum that may be associated with tumor growth.
Main Methods:
- Injection of blood serum from tumor-bearing mice into healthy mice.
- Proteomic analysis to identify proteins in the serum.
- Transplantation of Ehrlich's carcinoma in (CBA×C57Bl/6)F1 male mice.
Main Results:
- Serum from mice with Ehrlich's carcinoma stimulated the growth of transplanted tumors.
- New proteins were detected in the serum of tumor-bearing mice, with some being identified.
- The study provides evidence for tumor-associated factors in the serum.
Conclusions:
- The findings confirm the presence of tumor-specific factors in the serum that promote tumor growth.
- Combining proteomic methods with functional assays is a promising strategy for identifying and validating tumor-associated factors.
- Further research is warranted to explore the identified proteins as potential therapeutic targets or biomarkers for cancer.
